Clinical Evaluations, Treatment, Wrap Service and Forensic Evaluations RFSQ

The Utah Department of Health and Human Services (DHHS) is seeking qualified vendors for a Request for Statement of Qualifications (RFSQ) focused on Clinical Evaluations, Treatment, Wrap Service, and Forensic Evaluations (CETW). This procurement seeks professional service providers capable of delivering comprehensive clinical and forensic assessment services across multiple domains. The solicitation requires interested vendors to submit detailed qualifications demonstrating expertise in clinical evaluations, treatment methodologies, wrap services, and forensic assessment techniques. All solicitation documents are publicly available on the DHHS Purchasing site at https://dhhs.utah.gov/dhhspurchasing/dhhs91073/, with responses required to be emailed directly to susanstengel@utah.gov. The procurement timeline spans from the posting date of May 12, 2023, to a final due date of June 30, 2028, providing an extended opportunity for qualified vendors to participate. Potential respondents must carefully review all solicitation documents and submit any questions through the U3P platform, with guidance to review existing Q&A entries before submitting inquiries to avoid redundancy.

While specific set-aside designations are not explicitly detailed in the provided information, the procurement appears open to qualified professional service providers with demonstrated capabilities in clinical and forensic evaluation services. The broad scope suggests potential opportunities for various organizational types, including private practices, healthcare organizations, and specialized evaluation firms. No specific incumbent vendors or current contractors are mentioned in the solicitation details. The extended contract period of approximately five years indicates a significant long-term commitment from the Utah DHHS to establish a robust provider network for these critical evaluation services. Although precise award values or budget ranges are not specified in the current documentation, the comprehensive nature of the RFSQ suggests a potentially substantial procurement opportunity for qualified vendors with expertise in clinical and forensic evaluation methodologies.